Changchun High-Tech Industry (SHE:000661) subsidiary GeneScience received approval of the U.S. Food and Drug Administration to start clinical trials in the U.S. for GenSci145 tablets.
The drug is indicated for locally advanced or metastatic solid tumors with PIK3CA mutations, which occur in 30% to 40% of breast cancers, according to a Tuesday filing with the Shenzhen bourse.
Shares of the drug manufacturer closed 2% lower Tuesday.
Suzhou Zelgen Biopharmaceuticals (SHA:688266) presented two cancer drugs at the American Society of Clinical Oncology, according to a Shanghai bourse filing on Tuesday.The drugs presented were Nilvanstomig, which was developed as a treatment for hepatocellular carcinoma, and Alveltamig, a T-cell engager immunotherapy.Both drugs showed safety profiles during the clinical trials.
Muyuan Foods (HKG:2714; SHE:002714) granted Qin Yinglin the title honorary chairman, according to a Hong Kong filing on Tuesday.Qin, the food company's founder, resigned as chairman and president after reaching the mandatory retirement age.The company's Shenzhen shares dropped 3% at the close.
Semirara Mining and Power's (PSE:SCC) tax-exempt status on fuel imports has been upheld by the Supreme Court of the Philippines, according to a decision issued on Jan. 20 and released last week.Under the ruling, the government has been mandated to refund 27.3 million Philippine pesos collected as value-added tax to the company.The high court's Third Division upheld an earlier Court of Tax Appeals ruling in favor of the mining company after rejecting a petition filed by the Internal Revenue commissioner.The Local Government Code is limited to local government taxation and does not extend to national internal revenue taxes, Associate Justice Maria Filomena D. Singh wrote in the ruling.